Impulse Control and Related Disorders in Parkinson’s Disease

Impulse control disorders (ICDs), such as compulsive gambling, buying, sexual behavior, and eating, are a serious and increasingly recognized complication of dopamine replacement therapy in Parkinson’s disease (PD). Other impulsive-compulsive behaviors have been linked to dopaminergic medications; these include punding (stereotyped, repetitive, purposeless behaviors) and dopamine dysregulation syndrome (DDS; compulsive medication overuse). ICDs have been most closely related to the use of dopamine agonists (DAs), particularly at higher dosages; in contrast, DDS is primarily associated with shorter-acting, higher-potency dopaminergic medications, such as apomorphine and levodopa. Risk factors for ICDs may include male sex; younger age; younger age at PD onset; a pre-PD history of ICD(s); personal or family history of substance abuse; bipolar disorder; gambling problems; and impulsive personality traits. The primary treatment of ICDs in PD is discontinuation of DA therapy. Not all patients can tolerate this, however, due to worsening motor symptoms and/or DA withdrawal syndrome (a severe, stereotyped drug withdrawal syndrome similar to that of other psychostimulants). While psychiatric medications are frequently used to treat ICDs in the general population, there is no empirical evidence to suggest that they are effective in PD. Given the paucity of treatment options and potentially serious consequences of ICDs in PD, it is critical for patients to be monitored closely for their development. As empirically validated treatments for ICDs emerge, it will also be important to examine their efficacy and tolerability in individuals with comorbid PD.

[1]  T. Robbins,et al.  Functional implications of dopamine D1 vs. D2 receptors: A ‘prepare and select’ model of the striatal direct vs. indirect pathways , 2014, Neuroscience.

[2]  T. J. Moore,et al.  Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. , 2014, JAMA internal medicine.

[3]  Salvatore Nigro,et al.  Cortical volume and folding abnormalities in Parkinson's disease patients with pathological gambling. , 2014, Parkinsonism & related disorders.

[4]  A. Siderowf,et al.  Naltrexone for impulse control disorders in Parkinson disease , 2014, Neurology.

[5]  D. Weintraub,et al.  Impulse control and related disorders in Mexican Parkinson's disease patients. , 2014, Parkinsonism & related disorders.

[6]  A. Priori,et al.  Subthalamic involvement in monetary reward and its dysfunction in parkinsonian gamblers , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  P. Derost,et al.  Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  A. Moustafa,et al.  Impulse Control Disorders in Parkinson's Disease Are Associated with Dysfunction in Stimulus Valuation But Not Action Valuation , 2014, The Journal of Neuroscience.

[9]  M. Silber,et al.  Impulse control disorders in patients with dopamine agonist‐treated prolactinomas and nonfunctioning pituitary adenomas: a case–control study , 2014, Clinical endocrinology.

[10]  Jan Booij,et al.  Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[11]  M. Savasta,et al.  Pramipexole reverses Parkinson's disease‐related motivational deficits in rats , 2014, Movement disorders : official journal of the Movement Disorder Society.

[12]  L. Timmermann,et al.  Hypomania and mania related to dopamine replacement therapy in Parkinson's disease. , 2014, Parkinsonism & related disorders.

[13]  A. Bentivoglio,et al.  Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study , 2014, Psychiatry Research.

[14]  G. Deuschl,et al.  Alexithymia—an independent risk factor for impulsive‐compulsive disorders in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[15]  V. Fung,et al.  Effect of impulse control disorders on disability and quality of life in Parkinson’s disease patients , 2014, Journal of Clinical Neuroscience.

[16]  M. Mata,et al.  Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  M. Okun,et al.  Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa? , 2013, Movement disorders : official journal of the Movement Disorder Society.

[18]  E. López‐Valdés,et al.  Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[19]  A. Kishore,et al.  Impulse control disorders and related behaviors in Indian patients with Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[20]  S. Factor,et al.  Sleep and impulsivity in Parkinson's disease. , 2013, Parkinsonism & related disorders.

[21]  U. Bonuccelli,et al.  A Single-Center, Cross-Sectional Prevalence Study of Impulse Control Disorders in Parkinson Disease: Association With Dopaminergic Drugs , 2013, Journal of clinical psychopharmacology.

[22]  A. Priori,et al.  Pathological gambling in Parkinson's disease: Subthalamic oscillations during economics decisions , 2013, Movement disorders : official journal of the Movement Disorder Society.

[23]  R. Elliott,et al.  Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease. , 2013, Journal of neuropsychology.

[24]  A. Storch,et al.  Impulsiv-zwanghafte Verhaltensstörungen in einer deutschen Stichprobe ambulant versorgter Parkinson-Patienten , 2013, Fortschritte der Neurologie · Psychiatrie.

[25]  Valerie Voon,et al.  Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  J. Oliveira-Filho,et al.  Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease. , 2013, Parkinsonism & related disorders.

[27]  A. Bentivoglio,et al.  Neuropsychological features of patients with Parkinson’s disease and impulse control disorders , 2013, Neurological Sciences.

[28]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[29]  B. Averbeck,et al.  Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease. , 2013, Journal of Parkinson's disease.

[30]  P. Christos,et al.  Prospective cohort study of impulse control disorders in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[31]  A. David,et al.  Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers , 2013, Neurology.

[32]  B. Racette,et al.  Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States. , 2013, Parkinsonism & related disorders.

[33]  M. Zappia,et al.  Obsessive Compulsive Personality Disorder and Parkinson’s Disease , 2013, PloS one.

[34]  A. Siderowf,et al.  Screening for impulse control symptoms in patients with de novo Parkinson disease , 2013, Neurology.

[35]  Ji Hyun Ko,et al.  Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study , 2012, Neurobiology of Disease.

[36]  Thomas Foltynie,et al.  Decision making, impulsivity, and addictions: Do Parkinson's disease patients jump to conclusions? , 2012, Movement disorders : official journal of the Movement Disorder Society.

[37]  K. Richard Ridderinkhof,et al.  Dopamine Agonists and the Suppression of Impulsive Motor Actions in Parkinson Disease , 2012, Journal of Cognitive Neuroscience.

[38]  Eric Seigneuret,et al.  Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. , 2012, Brain : a journal of neurology.

[39]  A. Antonini,et al.  Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders. , 2012, Parkinsonism & related disorders.

[40]  T. Napier,et al.  Pramipexole-Induced Increased Probabilistic Discounting: Comparison Between a Rodent Model of Parkinson's Disease and Controls , 2012, Neuropsychopharmacology.

[41]  H. Chiang,et al.  Are there ethnic differences in impulsive/compulsive behaviors in Parkinson’s disease? , 2012, European journal of neurology.

[42]  Daniel Weintraub,et al.  Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating Scale , 2012, Movement disorders : official journal of the Movement Disorder Society.

[43]  A. Lang,et al.  Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine , 2012, Movement disorders : official journal of the Movement Disorder Society.

[44]  I. Leroi,et al.  Carer burden in apathy and impulse control disorders in Parkinson's disease , 2012, International journal of geriatric psychiatry.

[45]  R. Elliott,et al.  Apathy and impulse control disorders in Parkinson's disease: a direct comparison. , 2012, Parkinsonism & related disorders.

[46]  V. Voon,et al.  Impulse control disorders and depression in Finnish patients with Parkinson's disease. , 2012, Parkinsonism & related disorders.

[47]  G. Stebbins,et al.  Dopamine dysregulation syndrome item from the MDS‐UPDRS , 2012, Movement disorders : official journal of the Movement Disorder Society.

[48]  P. Soh,et al.  Impulsive-compulsive behaviors are common in Asian Parkinson's disease patients: assessment using the QUIP. , 2011, Parkinsonism & related disorders.

[49]  P. Llorca,et al.  Hypersexuality and pathological gambling in Parkinson's disease: A cross‐sectional case–control study , 2011, Movement disorders : official journal of the Movement Disorder Society.

[50]  T. Münte,et al.  Intertemporal choice in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[51]  P. Valkovič,et al.  Impulse Control Disorders Associated With Dopaminergic Medication in Patients With Pituitary Adenomas , 2011, Clinical neuropharmacology.

[52]  K Richard Ridderinkhof,et al.  The risky business of dopamine agonists in Parkinson disease and impulse control disorders. , 2011, Behavioral neuroscience.

[53]  Yasin Temel,et al.  Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. , 2011, Parkinsonism & related disorders.

[54]  B. Averbeck,et al.  Novelty seeking behaviour in Parkinson's disease , 2011, Neuropsychologia.

[55]  A. Lang,et al.  Impulse control disorders in parkinson disease: A multicenter case–control study , 2011, Annals of neurology.

[56]  M. Hallett,et al.  Dopamine agonists and risk: impulse control disorders in Parkinson's disease. , 2011, Brain : a journal of neurology.

[57]  B. Averbeck,et al.  Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[58]  P. Barone,et al.  Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[59]  Marios Politis,et al.  Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. , 2011, Brain : a journal of neurology.

[60]  B. Averbeck,et al.  Stroop test performance in impulsive and non impulsive patients with Parkinson's disease. , 2011, Parkinsonism & related disorders.

[61]  C. Adler,et al.  Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. , 2011, Parkinsonism & related disorders.

[62]  P. Barone,et al.  Impulsivity and compulsivity in drug‐naïve patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[63]  Angelo Antonini,et al.  Pathological gambling in patients with Parkinson's disease is associated with fronto‐striatal disconnection: A path modeling analysis , 2011, Movement disorders : official journal of the Movement Disorder Society.

[64]  A. Lang,et al.  Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional study , 2010, Annals of neurology.

[65]  K. R. Ridderinkhof,et al.  Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease. , 2010, Brain : a journal of neurology.

[66]  G. Belmonte,et al.  Parkinson's Disease and pathological gambling: Results from a functional MRI study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[67]  A. Lees,et al.  PAW21 Rewarding visual cues increase dopamine neurotransmission in Parkinson's patients with impulse control disorders: a PET study , 2010, Journal of Neurology Neurosurgery & Psychiatry.

[68]  B. Averbeck,et al.  Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[69]  S. Houle,et al.  Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD , 2010, Neurology.

[70]  E. Hollander,et al.  Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study , 2010, British Journal of Psychiatry.

[71]  Karl Mann,et al.  Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum. , 2010, Addiction.

[72]  M. Onofrj,et al.  Pathological gambling in Parkinson disease is reduced by amantadine , 2010, Annals of neurology.

[73]  J. Detre,et al.  Decreased ventral striatal activity with impulse control disorders in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[74]  D. Maraganore,et al.  Novelty seeking and introversion do not predict the long-term risk of Parkinson disease , 2010, Neurology.

[75]  Andrew J Lees,et al.  Intact Reward Learning but Elevated Delay Discounting in Parkinson's Disease Patients With Impulsive-Compulsive Spectrum Behaviors , 2010, Neuropsychopharmacology.

[76]  A. Strafella,et al.  Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling , 2010, Neurobiology of Disease.

[77]  S. Nakanishi,et al.  Distinct Roles of Synaptic Transmission in Direct and Indirect Striatal Pathways to Reward and Aversive Behavior , 2010, Neuron.

[78]  A. Lawrence,et al.  Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[79]  A. Lang,et al.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. , 2010, Archives of neurology.

[80]  L. Tremblay,et al.  Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. , 2010, Brain : a journal of neurology.

[81]  H. Cohen,et al.  Compulsive habits in restless legs syndrome patients under dopaminergic treatment , 2010, Journal of the Neurological Sciences.

[82]  Andrew J Lees,et al.  Excessive hoarding in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[83]  Han-Joon Kim,et al.  Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. , 2010, Parkinsonism & related disorders.

[84]  M. Hallett,et al.  Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors , 2010, Neuron.

[85]  M. Merello,et al.  Decision‐making in Parkinson’s disease patients with and without pathological gambling , 2010, European journal of neurology.

[86]  U. Bonuccelli,et al.  Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. , 2009, Parkinsonism & related disorders.

[87]  P. Chan,et al.  Impulse control disorders in Parkinson's disease in a Chinese population , 2009, Neuroscience Letters.

[88]  F. Durif,et al.  Evaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease , 2014 .

[89]  P. Pollak,et al.  [Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease]. , 2009, Revue neurologique.

[90]  Brian Knutson,et al.  Ventral Striatal Activation During Reward Anticipation Correlates with Impulsivity in Alcoholics , 2009, Biological Psychiatry.

[91]  B. Jeon,et al.  Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[92]  M. Gluck,et al.  Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. , 2009, Brain : a journal of neurology.

[93]  Daniel Weintraub,et al.  Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[94]  M. Baratti,et al.  Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive–compulsive behaviours associated to dopamine replacement therapy in Parkinson’s disease , 2009, Neurological Sciences.

[95]  S. Houle,et al.  Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. , 2009, Brain : a journal of neurology.

[96]  P. Barone,et al.  Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[97]  M Tagliati,et al.  Subthalamic deep brain stimulation and impulse control in Parkinson’s disease , 2009, European journal of neurology.

[98]  T. Robbins,et al.  Review Personality, Addiction, Dopamine: Insights from Parkinson's Disease Table 1. Possible Site of Striatal Dopamine Dysfunction Causing Different Motor and Cognitive Symptoms in Parkinson's Disease , 2022 .

[99]  A. Holman Impulse Control Disorder Behaviors Associated with Pramipexole Used to Treat Fibromyalgia , 2009, Journal of Gambling Studies.

[100]  Daniel Weintraub,et al.  Dopamine and impulse control disorders in Parkinson's disease , 2008, Annals of neurology.

[101]  A. Antonini,et al.  Functional abnormalities underlying pathological gambling in Parkinson disease. , 2008, Archives of neurology.

[102]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[103]  C. Patrick,et al.  Role of Serotonin and Dopamine System Interactions in the Neurobiology of Impulsive Aggression and its Comorbidity with other Clinical Disorders. , 2008, Aggression and violent behavior.

[104]  B. K. Hartman,et al.  A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. , 2008, The Journal of clinical psychiatry.

[105]  A. Siderowf,et al.  Long‐term follow‐up of impulse control disorders in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[106]  Michael J. Frank,et al.  Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism , 2007, Science.

[107]  V. Voon,et al.  Medication-related impulse control and repetitive behaviors in Parkinson disease. , 2007, Archives of neurology.

[108]  A. Lang,et al.  Punding prevalence in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[109]  Nir Giladi,et al.  New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset , 2007, Journal of psychopharmacology.

[110]  A. Lang,et al.  Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. , 2007, Archives of neurology.

[111]  M. Silber,et al.  Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists , 2007, Neurology.

[112]  M. D’Esposito,et al.  Reversal learning in Parkinson's disease depends on medication status and outcome valence , 2006, Neuropsychologia.

[113]  R. Cools Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease , 2006, Neuroscience & Biobehavioral Reviews.

[114]  G. Brighetti,et al.  Prevalence of pathological gambling in patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[115]  Y. Agid,et al.  Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation , 2006, Movement disorders : official journal of the Movement Disorder Society.

[116]  A. Lang,et al.  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease , 2006, Neurology.

[117]  P. Moberg,et al.  Association of dopamine agonist use with impulse control disorders in Parkinson disease. , 2006, Archives of neurology.

[118]  N. Volkow,et al.  Cocaine Cues and Dopamine in Dorsal Striatum: Mechanism of Craving in Cocaine Addiction , 2006, The Journal of Neuroscience.

[119]  A. Lang,et al.  Prospective prevalence of pathologic gambling and medication association in Parkinson disease , 2006, Neurology.

[120]  Yen F. Tai,et al.  Compulsive drug use linked to sensitized ventral striatal dopamine transmission , 2006, Annals of neurology.

[121]  C. Waters,et al.  Compulsive eating and weight gain related to dopamine agonist use , 2006, Movement disorders : official journal of the Movement Disorder Society.

[122]  T. Robbins,et al.  Neural systems of reinforcement for drug addiction: from actions to habits to compulsion , 2005, Nature Neuroscience.

[123]  Rüdiger Hilker,et al.  Decision-Making Impairments in Patients with Parkinson’s Disease , 2005, Behavioural neurology.

[124]  Michael J. Frank,et al.  By Carrot or by Stick: Cognitive Reinforcement Learning in Parkinsonism , 2004, Science.

[125]  C. Bjarkam,et al.  Therapeutic strategies for neurodegenerative disorders: Emerging clues from parkinson's disease , 2004, Biological Psychiatry.

[126]  Regina Katzenschlager,et al.  Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome , 2004, Movement disorders : official journal of the Movement Disorder Society.

[127]  R. Kurlan Disabling repetitive behaviors in Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[128]  P. Riederer,et al.  Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum , 2003, Journal of Neural Transmission.

[129]  M. Martín-Baranera,et al.  Does Nefazodone Improve Both Depression and Parkinson Disease? A Pilot Randomized Trial , 2003, Journal of clinical psychopharmacology.

[130]  M. Stacy,et al.  Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease , 2003, Neurology.

[131]  R. Bakay,et al.  Cognitive impairments in advanced PD without dementia , 2002, Neurology.

[132]  B. Everitt,et al.  Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex , 2002, Neuroscience & Biobehavioral Reviews.

[133]  Anthony A Grace,et al.  Opposite Influences of Endogenous Dopamine D1 and D2 Receptor Activation on Activity States and Electrophysiological Properties of Striatal Neurons: Studies CombiningIn Vivo Intracellular Recordings and Reverse Microdialysis , 2002, The Journal of Neuroscience.

[134]  C. Holden 'Behavioral' Addictions: Do They Exist? , 2001, Science.

[135]  Dan J Stein,et al.  Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. , 2001, Comprehensive psychiatry.

[136]  A. Lees,et al.  Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies , 2000, Journal of neurology, neurosurgery, and psychiatry.

[137]  R. Beninger,et al.  Dopamine D1-like Receptors and Reward-related Incentive Learning , 1998, Neuroscience & Biobehavioral Reviews.

[138]  M. Brandão,et al.  Effects of lesions of amygdaloid nuclei and substantia nigra on aversive responses induced by electrical stimulation of the inferior colliculus , 1996, Brain Research Bulletin.

[139]  Bernard Pillon,et al.  Cognitive deficits in Parkinson’s disease , 1996, Journal of Neurology.

[140]  L. Golbe,et al.  Dopamine‐related personality traits in Parkinson's disease , 1993, Neurology.

[141]  Bruno Giros,et al.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.

[142]  S. Landau,et al.  Motor phenotypes, medication and mood: further associations with impulsive behaviours in Parkinson's disease. , 2014, Journal of Parkinson's disease.

[143]  D. Weintraub,et al.  Impulsive and compulsive behaviors among Danish patients with Parkinson's disease: prevalence, depression, and personality. , 2014, Parkinsonism & related disorders.

[144]  Nikitin Av,et al.  [Impulsive-compulsive syndrome in Parkinson's disease]. , 2013 .

[145]  M. Kringelbach,et al.  A systematic review of impulse control disorders in Parkinson's disease. , 2013, Journal of Parkinson's disease.

[146]  L. Marsh,et al.  Improving detection of psychiatric disturbances in Parkinson's disease: the role of informants. , 2013, Journal of Parkinson's disease.

[147]  P. D. Blasi,et al.  Repetitive transcranial magnetic stimulation transiently reduces punding in Parkinson’s disease: a preliminary study , 2013, Journal of Neural Transmission.

[148]  Han-Joon Kim,et al.  Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease. , 2012, Parkinsonism & related disorders.

[149]  David Garcia-Garcia,et al.  Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. , 2011, Brain : a journal of neurology.

[150]  M. Nirenberg,et al.  Dopamine agonist withdrawal syndrome in Parkinson disease. , 2010, Archives of neurology.

[151]  M. Silber,et al.  Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. , 2010, Sleep.

[152]  Mark Hallett,et al.  Impulsive choice and response in dopamine agonist-related impulse control behaviors , 2009, Psychopharmacology.

[153]  J. Brewer,et al.  The neurobiology and genetics of impulse control disorders: relationships to drug addictions. , 2008, Biochemical pharmacology.

[154]  W. Ondo,et al.  Predictors of impulsivity and reward seeking behavior with dopamine agonists. , 2008, Parkinsonism & related disorders.

[155]  H. Katzen,et al.  Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease. , 2005, Advances in neurology.

[156]  Ronald J. Faber,et al.  Compulsive buying: descriptive characteristics and psychiatric comorbidity. , 1994, The Journal of clinical psychiatry.

[157]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.